Clik here to view.
Asia’s Largest Biotech Event, BIO KOREA 2023 to Be Held From May 10 to 12 in...
SEOUL, South Korea BIO KOREA 2023, Korea’s top Biotech event representing Asia, will take place from May 10th to 12th at COEX (C Hall) in Seoul. This press release features multimedia. View the full...
View ArticleClik here to view.
InnoCare Releases 2022 Annual Results and Business Highlights
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2022 annual results as of 31 December 2022. Dr....
View ArticleClik here to view.
Asia Youth Leaders Forum Opens in Nansha, Guangzhou
GUANGZHOU, China Guangzhou, one of the most developed Chinese cities, is building a communication and cooperation platform for Asian youth. This press release features multimedia. View the full...
View ArticleClik here to view.
インサイト、「ペマジール®」（ペミガチニブ）が骨髄／リンパ性腫瘍（MLN）患者の治療薬として日本で承認されたと発表
米デラウェア州ウィルミントン & 東京 （ビジネスワイヤ） — インサイト(Nasdaq:INCY)...
View ArticleClik here to view.
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK...
View ArticleClik here to view.
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results...
MENLO PARK, Calif. AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high...
View ArticleClik here to view.
CANbridge Announces Financial Results and Corporate Updates for Twelve Months...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (“CANbridge,” stock code 1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research,...
View ArticleClik here to view.
Fujirebio further extends its fully automated blood-based biomarker portfolio...
GENT, Belgium & MALVERN, Pa. & TOKYO H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G ApoE4 and Lumipulse G Pan-ApoE...
View ArticleClik here to view.
Joe Kiani荣获2023年Robert L. Wears患者安全领导奖
加州尔湾 (美国商业资讯)–患者安全运动基金会(PSMF)的创始人Joe Kiani与MedStar质量与安全研究所负责患者安全的副总裁Kathryn Kellogg博士一起被授予2023年Robert L. Wears患者安全领导奖个人类奖项。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ジョー・キアニが2023年ロバート・L・ウェアーズ患者安全リーダーシップ賞を受賞
米カリフォルニア州アーバイン （ビジネスワイヤ） — 患者安全運動財団（PSMF）の創設者であるジョー・キアニは、2023年ロバート・L・ウェアーズ患者安全リーダーシップ賞の個人部門で、メドスター・インスティチュート・フォー・クオリティー＆セーフティーの患者安全担当バイスプレジデントであるキャスリン・ケロッグ医師と共に受賞しました。...
View ArticleClik here to view.
JCR Pharmaceuticals Announces Research Collaboration, Option and License...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) today announced that JCR has signed a Research Collaboration, Option and License Agreement with...
View ArticleClik here to view.
PharmaJet Partner Gennova Biopharmaceuticals Seeks Emergency Use...
GOLDEN, Colo. Following assessment of the primary endpoints of the Phase II/III study, PharmaJet partner Gennova Biopharmaceuticals Limited has submitted data for its mRNA-based Omicron specific...
View ArticleClik here to view.
athenahealth and Smile Foundation Launch Second Mobile Medical Unit in Bengaluru
WATERTOWN, Mass. athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, and Smile Foundation today announced the expansion...
View ArticleClik here to view.
Pharmaron’s Liverpool UK Gene Therapy CDMO Commences Major Site Expansion...
BEIJING Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK...
View ArticleClik here to view.
AN2 Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results...
MENLO PARK, Calif. AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high...
View ArticleClik here to view.
CANbridge Announces Financial Results and Corporate Updates for Twelve Months...
BEIJING & CAMBRIDGE, Mass. CANbridge Pharmaceuticals, Inc. (“CANbridge,” stock code 1228.HK), a global biopharmaceutical company, with a foundation in China, committed to the research,...
View ArticleClik here to view.
Fujirebio further extends its fully automated blood-based biomarker portfolio...
GENT, Belgium & MALVERN, Pa. & TOKYO H.U. Group Holdings Inc. and its wholly-owned subsidiary Fujirebio today announced the availability of the Lumipulse G ApoE4 and Lumipulse G Pan-ApoE...
View ArticleClik here to view.
Joe Kiani荣获2023年Robert L. Wears患者安全领导奖
加州尔湾 (美国商业资讯)–患者安全运动基金会(PSMF)的创始人Joe Kiani与MedStar质量与安全研究所负责患者安全的副总裁Kathryn Kellogg博士一起被授予2023年Robert L. Wears患者安全领导奖个人类奖项。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ジョー・キアニが2023年ロバート・L・ウェアーズ患者安全リーダーシップ賞を受賞
米カリフォルニア州アーバイン （ビジネスワイヤ） — 患者安全運動財団（PSMF）の創設者であるジョー・キアニは、2023年ロバート・L・ウェアーズ患者安全リーダーシップ賞の個人部門で、メドスター・インスティチュート・フォー・クオリティー＆セーフティーの患者安全担当バイスプレジデントであるキャスリン・ケロッグ医師と共に受賞しました。...
View ArticleClik here to view.
JCR Pharmaceuticals Announces Research Collaboration, Option and License...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) today announced that JCR has signed a Research Collaboration, Option and License Agreement with...
View Article